S H Kelkar and Company Limited
Valuation (45/100) does the heavy lifting; momentum (18/100) is the drag.
Fair valueSolvency riskS H Kelkar and Company Limited earns a Strong Sell from StocksWizard, with a blended score of 29/100. We put fair value near ₹125.94; at ₹141.22 that leaves roughly 11% downside, so the stock screens fairly valued. On 28.1x trailing earnings it sits pricier than the Basic Materials median of about 22.2x. The price is about 44% below its 52-week high of ₹250.85 and 26% above the low of ₹112.34. Financial health scores 29/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹270 implies about 91% upside across 1 analysts. It clears 1 of 13 investability checks, with durability 24, valuation 57 and momentum 18 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹100.75.
Analyst views
1-year price
EOD · 2026-09-1452-week range
-43.70% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Strong Sell29Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 5.2%
- Fail: Low debt (D/E < 0.5): 0.76x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 14%
- Fail: Earnings growing: -98%
- Fail: Net margin ≥ 10%: 2.9%
- Fail: Current ratio > 1.5: 1.27
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.15
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter66.9%
- Institutions11.9%
- Public & other21.2%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Revenue growing (14% YoY).
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Low return on equity (5.2%).
- Price below its 200-day moving average (downtrend).
Threats
- Earnings contracting year on year.
About S H Kelkar and Company Limited
S H Kelkar and Company Limited, together with its subsidiaries, manufactures and supplies fragrances, flavors, and aroma ingredients in India. Its fragrances are used in personal care, fabric care, skin care, hair care, fine fragrances, and home care products, as well as flavors are used in baked, dairy, beverages, savoury, and pharmaceutical products. The company is also involved in microbiology, biotechnology, cosmetic, custom synthesis, and cosmetic biotechnology research
S H Kelkar and Company Limited — frequently asked questions
Is S H Kelkar and Company Limited a buy, hold or sell?
StocksWizard currently rates S H Kelkar and Company Limited (SHK) a Strong Sell, based on a blended score of 29/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is S H Kelkar and Company Limited's fair value?
Our blended DCF and relative-valuation model estimates S H Kelkar and Company Limited's fair value at about ₹125.94, versus a current price of ₹141.22 — roughly 11% downside. On that basis the stock looks fairly valued.
Is S H Kelkar and Company Limited financially healthy?
S H Kelkar and Company Limited scores 29/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has S H Kelkar and Company Limited's share price performed?
S H Kelkar and Company Limited is up 5% over three months, and last traded at ₹141.22. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.